Abstract
Sinoatrial node cardiomyocytes (SANcm) possess automatic, rhythmic electrical activity. SAN rate is influenced by autonomic nervous system input, including sympathetic nerve increases of heart rate (HR) via activation of β-adrenergic receptor signaling cascade (β-AR). L-type calcium channel (LTCC) activity contributes to membrane depolarization and is a central target of β-AR signaling. Recent studies revealed that the small G-protein Rad plays a central role in β-adrenergic receptor directed modulation of LTCC. These studies have identified a conserved mechanism in which β-AR stimulation results in PKA-dependent Rad phosphorylation: depletion of Rad from the LTCC complex, which is proposed to relieve the constitutive inhibition of CaV1.2 imposed by Rad association. Here, using a transgenic mouse model permitting conditional cardiomyocyte selective Rad ablation, we examine the contribution of Rad to the control of SANcm LTCC current (ICa,L) and sinus rhythm. Single cell analysis from a recent published database indicates that Rad is expressed in SANcm, and we show that SANcm ICa,L was significantly increased in dispersed SANcm following Rad silencing compared to those from CTRL hearts. Moreover, cRadKO SANcm ICa,L was not further increased with β-AR agonists. We also evaluated heart rhythm in vivo using radiotelemetered ECG recordings in ambulating mice. In vivo, intrinsic HR is significantly elevated in cRadKO. During the sleep phase cRadKO also show elevated HR, and during the active phase there is no significant difference. Rad-deletion had no significant effect on heart rate variability. These results are consistent with Rad governing LTCC function under relatively low sympathetic drive conditions to contribute to slower HR during the diurnal sleep phase HR. In the absence of Rad, the tonic modulated SANcm ICa,L promotes elevated sinus HR. Future novel therapeutics for bradycardia targeting Rad – LTCC can thus elevate HR while retaining βAR responsiveness.
Original language | English |
---|---|
Pages (from-to) | 60-69 |
Number of pages | 10 |
Journal | Journal of Molecular and Cellular Cardiology |
Volume | 154 |
DOIs | |
State | Published - May 2021 |
Bibliographical note
Publisher Copyright:© 2021 Elsevier Ltd
Funding
This research was funded by National Institutes of Health (NIH), NHLBI R01 HL131782 (DAA, JS), Department of Defense , United States W81XWH-20-1-0418 (DAA, JS), AHA pre-doctoral fellowship to BMA ( 19PRE34380909 ), and Institutional Development Award (IDeA) from NIH NIGMS P30 GM127211 .
Funders | Funder number |
---|---|
National Institutes of Health (NIH) | |
U.S. Department of Defense | |
National Heart, Lung, and Blood Institute (NHLBI) | R01 HL131782 |
National Institute of General Medical Sciences | P30GM127211 |
American the American Heart Association | 19PRE34380909 |
University of California Institute for Mexico and the United States | W81XWH-20-1-0418 |
Keywords
- Cardiomyocyte
- Heart rate regulation
- Heart rhythm
- L-type calcium channel
ASJC Scopus subject areas
- Molecular Biology
- Cardiology and Cardiovascular Medicine